Role of IL-6 and IL-6 targeted therapy in systemic lupus erythematosus-Reference-Cited by-同舟云学术

Role of IL-6 and IL-6 targeted therapy in systemic lupus erythematosus

Published:2023-08-18 Issue:12 Volume:62 Page:3804-3810
ISSN:1462-0324
Container-title:Rheumatology
language:en
Short-container-title:

Author:

Nepal Desh¹^ORCID,Gazeley David¹

Affiliation:

1. Division of Rheumatology, Department of Medicine, Medical College of Wisconsin , Milwaukee, WI, USA

Abstract

Abstract Interleukin-6 (IL-6) is one of the cytokines implicated in murine and human SLE. Only a few small studies have investigated IL-6 inhibition in human SLE. Currently, there are no studies registered in clinicaltrials.gov to assess the IL-6 targeted therapy in SLE, yet its role in the future remains to be defined. This narrative review analyses these and potential areas of future studies with IL-6 targeted therapy in SLE.

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

https://academic.oup.com/rheumatology/advance-article-pdf/doi/10.1093/rheumatology/kead416/51405459/kead416.pdf

Reference65 articles.

1. Two-year, randomized, controlled trial of belimumab in lupus nephritis;Furie;N Engl J Med,2020

2. Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus;Chun;J Clin Immunol,2007

3. Loss of the interleukin-6 receptor causes immunodeficiency, atopy, and abnormal inflammatory responses;Spencer;J Exp Med,2019

4. Tocilizumab in rheumatoid arthritis: a meta-analysis of efficacy and selected clinical conundrums;Navarro;Semin Arthritis Rheum,2014

5. Longterm safety and effectiveness of the anti-interleukin 6 receptor monoclonal antibody tocilizumab in patients with systemic juvenile idiopathic arthritis in Japan;Yokota;J Rheumatol,2014

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Frequency Evaluation of the Interleukin-6 −174G>C Polymorphism and Homeostatic Iron Regulator (HFE) Mutations as Disease Modifiers in Patients Affected by Systemic Lupus Erythematosus and Rheumatoid Arthritis;International Journal of Molecular Sciences;2023-11-14